Pharma & API (Q1 FY25)
Stealth bull run in formulation players continues, API players continue to struggle The stock price performance of the pharma players should drill home the importance of diversification at all point of time. No noise, no big buzz, just steady price performance for many quarters now. While themes like ship building, defense, PSU, power, Infra, Capital…